Catalent’s expert workforce exceeds 19,000, including more than 2,500 scientists and technicians.
Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year.
At Catalent, we share a common goal, to put patients first and help people around the world live better and healthier lives.
Our Mission is to develop, manufacture and supply products that help people live better and healthier lives.
Vision
Our vision is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations, while driving strong, sustained growth for the company.
Our Values
- Patient First
We put patients at the center of our work to ensure the safety, reliable supply and optimal performance of our products. - People
We are committed to the growth, development and engagement of our people. - Integrity
We demonstrate respect, accountability and honesty in every interaction. - Customer Dedication
We strive to exceed our customers’ expectations every day. - Innovation
We create innovative solutions, employ superior technologies and continuously improve our processes. - Excellence
We have a passion for excellence in everything we do.
Our product development expertise has lead to formulation advancements which have expanded the applications of our industry-leading softgel technologies platform to enable formulations that can enhance the patient experience and product safety in multiple ways. We developed OptiGel® Lock as an abuse-deterrent technology for controlled substances, leveraging the inherent properties of softgel technology to enable and prevent misuse while delivering needed benefits to patients. With the growth of large molecule therapies, particularly proteins and peptides, our team innovated OptiGel® BIO as a way to deliver these molecules orally, again leveraging softgel technology to both stabilize and enhance absorption of large molecules while potentially greatly improving patient adherence and compliance.
The rapidly changing nature of clinical trials provides opportunities for Catalent to support the needs of our customers today and the future. From our FastChain® demand led supply service, to complex cold chain logistics for sensitive biologics to direct-to-patient shipments, we are prepared to exceed our customers’ expectations on all dimensions. An important service that we offer which many of our smaller customers have tapped into with great success is our clinical supply management services. With CTSuccess™, we proactively seek to understand clinical supply challenges a sponsor may face based upon their study design and what steps we can take to address those challenges even before the study starts. Our experts work in close collaboration with our customers to establish a sound clinical supply strategy to get off to the best possible start and keep their study on track. With nine clinical supply facilities and 50+ depots across the globe, Catalent can help bring your product to the clinic anywhere in the world. In April 2019, Catalent opened its second facility in Shanghai, China. The new facility, located outside of the free trade zone (FTZ) in Tangzhen, is near both Catalent’s existing Waigaoqiao FTZ facility and China’s Zhangjiang Pharma Valley area. Catalent Clinical Supplies two facilities located both inside and outside the FTZ offers our customers flexibility, convenience and streamlined logistics in support of the growing number of trials being conducted in the region.
To learn the latest expert insights on technologies and capabilities for pharmaceuticals, biologics and over the counter products, please visit https://pharma.catalent.com/expert-content
Catalent. More products. Better treatments. Reliably Supplied. ™
We have over 1000 products in development at any time and have extensive partnerships with pharmaceutical and biopharmaceutical companies of all sizes, from small or virtual organizations to large multinationals. We scale our approach according to what our customers need for their program to be a success.
